Controlled and directed drug elution by the Abluminal Reservoir Technology, without the use of any polymer.
Maximized efficacy, especially in Diabetic Patients, due to the proprietary Amphilimus™ formulation, a combination of Sirolimus and Fatty Acid.
Proven haemo/biocompatibility enabled by the Bio Inducer Surface, which accelerates the rate of endothelialization and reduces thrombogenicity.
The images shown within this pages are of a purely illustrative nature and not intended to depict reality. Manufactured by CID S.p.A member of Alvimedica Group.
